Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solvent Optimization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101538255B details a greener synthesis for SMIA using butyl acetate, reducing solvent loss and byproducts for reliable pharmaceutical intermediate supply.
Patent CN102952147A reveals ethyl acetate solvent system improving sulbactam yield. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Analysis of patent CN103772401A reveals a novel ethyl acetate refining method for Asenapine intermediates, boosting yield to 98% and ensuring high purity for pharmaceutical manufacturing.
Discover the advanced CN114853734A method for Nilotinib free base synthesis. Achieve higher purity and yield with optimized solvent systems for cost-effective manufacturing.
Novel formic acid solvent method boosts yield for coptisine halide salt production ensuring cost efficiency and supply reliability for pharmaceutical partners.
Patent CN100349858C reveals solvent innovation for high-purity iohexol production reducing impurities and enhancing supply chain reliability for contrast agents.
Patent CN1298402A reveals a safer synthesis route for anti-arrhythmic agents, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Discover metal-free β-iodonitroalkene synthesis with 80%+ yields. Eliminate oxidant risks & simplify GMP production for API intermediates.
Solve high-cost synthesis challenges with this metal-free method for pharmaceutical intermediates. Eliminate heavy metal catalysts and reduce production risks. Contact for scalable manufacturing.
Solve low yield and impurity issues in camptothecin synthesis. New deprotection method cuts solvent use, boosts purity to 99.9% and recovers mother liquor for cost savings.
Solve supply chain risks with metal-free, high-yield synthesis of trifluoromethyl selenium azaspiro[4,5]-tetraenone. Reduce costs and ensure 99% purity for drug development.
Solve metal-catalyst dependency & low yields in 3-phenylselenyl-1-propanone synthesis. Get air-stable, high-purity intermediates for drug development with 70-82% yields. Contact for CDMO solutions.
Discover a metal-free, one-pot method for 4-quinolone synthesis with 84% yield. Eliminate catalyst costs and complex purification. Contact us for scalable CDMO solutions.
Discover cost-effective, metal-free synthesis of trifluoromethyl selenium azaspiro[4,5]-tetraenone with high yield and no heavy metal catalysts. Reduce supply chain risks for your pharmaceutical intermediates.
Avoid toxic reagents and costly impurities in cinacalcet production. Our scalable, eco-friendly process ensures 99.7% purity and supply chain stability for pharma R&D.